Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3087221rdf:typepubmed:Citationlld:pubmed
pubmed-article:3087221lifeskim:mentionsumls-concept:C1280551lld:lifeskim
pubmed-article:3087221lifeskim:mentionsumls-concept:C0234421lld:lifeskim
pubmed-article:3087221lifeskim:mentionsumls-concept:C1705480lld:lifeskim
pubmed-article:3087221lifeskim:mentionsumls-concept:C1289957lld:lifeskim
pubmed-article:3087221lifeskim:mentionsumls-concept:C0311417lld:lifeskim
pubmed-article:3087221lifeskim:mentionsumls-concept:C0392756lld:lifeskim
pubmed-article:3087221lifeskim:mentionsumls-concept:C0030685lld:lifeskim
pubmed-article:3087221lifeskim:mentionsumls-concept:C0680255lld:lifeskim
pubmed-article:3087221lifeskim:mentionsumls-concept:C0391871lld:lifeskim
pubmed-article:3087221lifeskim:mentionsumls-concept:C1283071lld:lifeskim
pubmed-article:3087221lifeskim:mentionsumls-concept:C1963578lld:lifeskim
pubmed-article:3087221pubmed:issue6 Pt 2lld:pubmed
pubmed-article:3087221pubmed:dateCreated1986-7-24lld:pubmed
pubmed-article:3087221pubmed:abstractTextBoth in vivo as well as in vitro experiments suggest that prostaglandins (PG) may influence arginine vasopressin (AVP) release. Recent studies on conscious dogs have shown that cyclooxygenase inhibition with meclofenamate reduces basal AVP release as well as AVP release in response to hypoxia. The current experiments were performed in order to test whether PG synthesis inhibition affects osmotic- and nonosmotic-stimulated AVP release in a similar manner. Osmotic AVP release was tested by slowly infusing hypertonic saline intravenously in water-diuresing dogs and serially sampling plasma for AVP concentration. Experiments were performed both with and without meclofenamate (2 mg/kg and 2 mg X kg-1 X h-1 iv) pretreatment. AVP release to a comparable osmotic stimulus was greatly reduced after meclofenamate administration. Nonosmotic AVP release was tested by inducing systemic hypotension with an intravenous infusion of nitroprusside. Hypotension was associated with an increase in AVP concentration, which was partially blunted after meclofenamate administration. Experiments performed with only a saline vehicle administered showed no decrease in AVP release in response to comparable hypotension. The findings of these studies suggest that endogenous PG may be involved in both osmotic and nonosmotic AVP release in the conscious dog.lld:pubmed
pubmed-article:3087221pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3087221pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3087221pubmed:languageenglld:pubmed
pubmed-article:3087221pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3087221pubmed:citationSubsetIMlld:pubmed
pubmed-article:3087221pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3087221pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3087221pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3087221pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3087221pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3087221pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3087221pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3087221pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3087221pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3087221pubmed:statusMEDLINElld:pubmed
pubmed-article:3087221pubmed:monthJunlld:pubmed
pubmed-article:3087221pubmed:issn0002-9513lld:pubmed
pubmed-article:3087221pubmed:authorpubmed-author:BeriSSlld:pubmed
pubmed-article:3087221pubmed:authorpubmed-author:BurkeT JTJlld:pubmed
pubmed-article:3087221pubmed:authorpubmed-author:ArnoldP EPElld:pubmed
pubmed-article:3087221pubmed:authorpubmed-author:EricksonA LALlld:pubmed
pubmed-article:3087221pubmed:authorpubmed-author:WalkerB RBRlld:pubmed
pubmed-article:3087221pubmed:issnTypePrintlld:pubmed
pubmed-article:3087221pubmed:volume250lld:pubmed
pubmed-article:3087221pubmed:ownerNLMlld:pubmed
pubmed-article:3087221pubmed:authorsCompleteYlld:pubmed
pubmed-article:3087221pubmed:paginationR1028-33lld:pubmed
pubmed-article:3087221pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:3087221pubmed:meshHeadingpubmed-meshheading:3087221-...lld:pubmed
pubmed-article:3087221pubmed:meshHeadingpubmed-meshheading:3087221-...lld:pubmed
pubmed-article:3087221pubmed:meshHeadingpubmed-meshheading:3087221-...lld:pubmed
pubmed-article:3087221pubmed:meshHeadingpubmed-meshheading:3087221-...lld:pubmed
pubmed-article:3087221pubmed:meshHeadingpubmed-meshheading:3087221-...lld:pubmed
pubmed-article:3087221pubmed:meshHeadingpubmed-meshheading:3087221-...lld:pubmed
pubmed-article:3087221pubmed:meshHeadingpubmed-meshheading:3087221-...lld:pubmed
pubmed-article:3087221pubmed:meshHeadingpubmed-meshheading:3087221-...lld:pubmed
pubmed-article:3087221pubmed:meshHeadingpubmed-meshheading:3087221-...lld:pubmed
pubmed-article:3087221pubmed:meshHeadingpubmed-meshheading:3087221-...lld:pubmed
pubmed-article:3087221pubmed:meshHeadingpubmed-meshheading:3087221-...lld:pubmed
pubmed-article:3087221pubmed:meshHeadingpubmed-meshheading:3087221-...lld:pubmed
pubmed-article:3087221pubmed:meshHeadingpubmed-meshheading:3087221-...lld:pubmed
pubmed-article:3087221pubmed:meshHeadingpubmed-meshheading:3087221-...lld:pubmed
pubmed-article:3087221pubmed:meshHeadingpubmed-meshheading:3087221-...lld:pubmed
pubmed-article:3087221pubmed:meshHeadingpubmed-meshheading:3087221-...lld:pubmed
pubmed-article:3087221pubmed:year1986lld:pubmed
pubmed-article:3087221pubmed:articleTitleReduced osmotic and nonosmotic release of vasopressin after meclofenamate in the conscious dog.lld:pubmed
pubmed-article:3087221pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3087221pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed